List view / Grid view

Targets

 

webinar

Neurological disorders: organoids for early drug discovery

14 March 2024 | By Drug Target Review

Join us for this webinar as we explore the role of organoids in advancing treatment of neurological disorders. Organoids, miniature 3D models of human organs, are at the forefront of neuroscience research, offering insights into the complexities of the human brain. In this webinar, esteemed experts will explore the latest…

article

Women in Stem with Leila Jaafar

5 March 2024 | By

After gaining her PhD in Biophysics as an International Max-Planck Research School scholar, Leila joined the nuclear field in 2006, starting as an engineer in radiation protection and neutron fluence. Throughout Leila’s career, she has worked across multiple disciplines as a technical project lead in nuclear engineering, lastly in the…

article

The future of cancer immunotherapy with Elicio Therapeutics

1 March 2024 | By ,

In this exclusive interview with Dr Christopher Haqq, Executive Vice President, Head of Research and Development, and Chief Medical Officer of Elicio Therapeutics, we explore the latest in Cancer Immunology Research. The study highlights the promising preclinical data demonstrating the potential of TCR-T cell therapy in combination with lymph node-targeted…

whitepaper

Beyond the lab: artificial intelligence

28 February 2024 | By

Amidst the transformative era of artificial intelligence in drug discovery, this report focuses on recent advancements, notably the development of highly accurate drug target models, and how AI is revolutionising precision and effectiveness in identifying drug targets.